logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Alopecia Areata

    FiltersReset Filters
    16 results

    • celestone soluspan

      (Betamethasone Acetate and Betamethasone Sodium Phosphate)
      Organon LLC
      Usage: CELESTONE SOLUSPAN Injectable Suspension is indicated for treating severe allergic conditions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, and various hematologic disorders. It is also used for certain neoplastic diseases, nervous system issues, ophthalmic diseases, renal diseases, respiratory diseases, rheumatic disorders, and specific dermatological conditions via different administration routes.

    • depo-medrol

      (methylprednisolone acetate)
      Pharmacia & Upjohn Company LLC
      Usage: DEPO-MEDROL is indicated for severe allergic states, dermatoses, endocrine and gastrointestinal disorders, hematologic conditions, certain neoplasms, and respiratory diseases. It also treats nervous system issues, renal problems, and rheumatic diseases. Additionally, it can be administered intra-articularly for arthritis and intralesionally for specific dermatologic conditions.

    • depo-medrol

      (methylprednisolone acetate)
      Pharmacia & Upjohn Company LLC
      Usage: DEPO-MEDROL is indicated for various conditions, including severe allergic reactions, dermatologic diseases, endocrine and gastrointestinal disorders, hematologic issues, and certain rheumatic diseases. It is also used for cerebral edema, palliative care in neoplastic diseases, and localized therapies in dermatologic conditions via intralesional or intra-articular administration.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Amneal Pharmaceuticals LLC
      Usage: This drug is indicated for various conditions, including endocrine and rheumatic disorders, allergic states, gastrointestinal diseases, respiratory diseases, hematologic disorders, and certain dermatologic and ophthalmic diseases. It can be administered intravenously, intramuscularly, intra-articular, or intralesionally for acute episodes and management of chronic conditions.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Civica, Inc.
      Usage: This drug is indicated for various conditions, including endocrine disorders (like adrenocortical insufficiency), rheumatic and collagen diseases, severe allergic reactions, dermatologic and gastrointestinal diseases, respiratory issues, hematologic conditions, neoplastic diseases, and neurological disorders. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally as appropriate.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Fresenius Kabi USA, LLC
      Usage: The drug is indicated for various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., arthritis), collagen diseases, dermatologic diseases, severe allergic conditions, ophthalmic diseases, gastrointestinal and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, nervous system issues, and miscellaneous conditions.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Mylan Institutional LLC
      Usage: This drug is indicated for various conditions including adrenocortical insufficiency, rheumatic and collagen diseases, severe allergic reactions, ophthalmic and respiratory diseases, gastrointestinal diseases, hematologic disorders, neoplastic diseases, and cerebral edema. It can be administered via intravenous, intramuscular, intra-articular, or intralesional injections.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Somerset Therapeutics, LLC
      Usage: This drug is indicated for intravenous or intramuscular use in endocrine disorders, rheumatic disorders, collagen diseases, dermatologic conditions, severe allergic states, ophthalmic diseases, gastrointestinal and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, and acute exacerbations of multiple sclerosis, among other conditions.

    • litfulo

      (ritlecitinib)
      Pfizer Laboratories Div Pfizer Inc
      Usage: LITFULO is a kinase inhibitor indicated for treating severe alopecia areata in adults and adolescents aged 12 and older. It is not recommended for use with other JAK inhibitors, biologic immunomodulators, cyclosporine, or potent immunosuppressants.

    • litfulo

      (ritlecitinib)
      U.S. Pharmaceuticals
      Usage: LITFULO is indicated for treating severe alopecia areata in adults and adolescents aged 12 and older. It should not be used with other JAK inhibitors, biologic immunomodulators, cyclosporine, or potent immunosuppressants.